PRKACB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.331400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.599600E-01
Normal-vs-Stage2
8.227600E-01
Normal-vs-Stage3
2.294000E-01
Normal-vs-Stage4
6.413400E-01
Stage1-vs-Stage2
2.901800E-01
Stage1-vs-Stage3
2.692800E-01
Stage1-vs-Stage4
9.314200E-01
Stage2-vs-Stage3
2.818200E-01
Stage2-vs-Stage4
4.521600E-01
Stage3-vs-Stage4
2.746500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.159800E-01
Normal-vs-AfricanAmerican
7.911800E-01
Normal-vs-Asian
7.118400E-01
Caucasian-vs-AfricanAmerican
5.411800E-01
Caucasian-vs-Asian
7.228200E-01
AfricanAmerican-vs-Asian
4.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.168000E-01
Normal-vs-Female
8.937000E-01
Male-vs-Female
9.195700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.899200E-01
Normal-vs-Age(41-60Yrs)
9.057200E-01
Normal-vs-Age(61-80Yrs)
8.976600E-01
Normal-vs-Age(81-100Yrs)
6.624800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.486800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.158200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.830400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.607800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.553800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.189200E-01
Normal-vs-Daily Drinker
1.043750E-01
Normal-vs-Weekly Drinker
3.060400E-01
Normal-vs-Occasional Drinker
8.030000E-01
Normal-vs-Social Drinker
6.280800E-01
Non Drinker-vs-Daily Drinker
1.351620E-01
Non Drinker-vs-Weekly Drinker
4.694000E-01
Non Drinker-vs-Occasional Drinker
2.317800E-01
Non Drinker-vs-Social Drinker
1.091650E-01
Daily Drinker-vs-Weekly Drinker
5.773600E-01
Daily Drinker-vs-Occasional Drinker
8.145600E-02
Daily Drinker-vs-Social Drinker
3.726400E-02
Weekly Drinker-vs-Occasional Drinker
1.366800E-01
Weekly Drinker-vs-Social Drinker
6.323500E-02
Occasional Drinker-vs-Social Drinker
6.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.006600E-01
Normal-vs-Grade 2
1.773240E-01
Normal-vs-Grade 3
2.701200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.841630E-01
Grade 1-vs-Grade 3
3.757600E-01
Grade 1-vs-Grade 4
3.006600E-01
Grade 2-vs-Grade 3
4.993800E-01
Grade 2-vs-Grade 4
1.773240E-01
Grade 3-vs-Grade 4
2.701200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.807600E-01
Normal-vs-NonDiabetic
9.283000E-01
Diabetic-vs-NonDiabetic
7.042200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.586800E-01
Normal-vs-NoPancreatitis
8.956800E-01
Pancreatitis-vs-NoPancreatitis
2.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.282400E-01
Normal-vs-N1
8.677000E-01
N0-vs-N1
4.441800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.637000E-01
Normal-vs-TP53-NonMutant
7.064600E-01
TP53-Mutant-vs-TP53-NonMutant
8.563000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
